Quantification of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen

Journal of Surgical Oncology

Volumn 90, Issue 2, 2005, Pages 77-80

  Da Silva, Benedito Borges ^a,b,c   Da Silva Jr , Raimundo Gerônimo ^a   Borges, Umbelina Soares ^a   Da Silveira Filho, Marcos Antônio Guedes ^a   Pimentel, Igor Clausius Carvalho ^a   Gebrim, Luiz Henrique ^b   De Jesus Simões, Manuel ^b   Baracat, Edmund Chada ^b  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Bairro Jockey Club ^*  (Brazil)

Author keywords

Angiogenesis; Breast carcinoma; Rabbit cornea; Tamoxifen

Indexed keywords

HEMATOXYLIN; TAMOXIFEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAZIL; BREAST CARCINOMA; CORNEA; CORNEA LIMBUS; DENSITY; DRUG EFFECT; FEMALE; HUMAN; MICROVASCULATURE; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; STUDENT T TEST;

ANIMALS; BREAST NEOPLASMS; CORNEA; EYE NEOPLASMS; FEMALE; HUMANS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; POSTMENOPAUSE; RABBITS; TAMOXIFEN;

EID: 17844381278     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20239     Document Type: Article

References (19)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Weidner N, Semple JP, Welche WR, et al.: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
3. Folkman J: Angiogenesis and breast cancer. J Clin Oncol 1994; 12:441-443.
4. Kurmar S, Ghellal A, Li C, et al.: Breast carcinoma: Vasculature density determined using CD 105 antibody correlates with tumor prognosis. Cancer Res 1994;59:856-861.
5. Blackwell KL, Haroon ZA, Shan S, et al.: Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000;6:4359-4364.
6. Micaela M, Buckey T, Goa KL: Tamoxifen, a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drug 1989;37:451.
7. Jordan VC: An overview of considerations for testing of tamoxifen as a preventive for breast cancer. Ann N Y Acad Sci 1995;768:141.
8. Marson LP, Kurian KM, Miller WR, et al.: The effect of tamoxifen on breast tumour vasculaturity. Breast Cancer Res Treat 2001;66:9-15.
9. Weidner U, Folkman J, Pozza F, et al.: Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;10:1875-1877.
10. Abulafa O, Sherer DM: Angiogenesis in the uterine cervix. Int J Gynecol Cancer 2000;10:349-357.
11. Brem H, Folkman J: Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 1975;141:427-439.
12. Gross J, Azizjhan RG, Bisvas C, et al.: Inhibition of tumor growth vascularization and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Nat Acad Sci USA 1981;78:1176-1180.
13. Jikiahara H, Nobuy wkit T, Yamamoto R, et al.: Inhibition effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. Am J Obstet Gynecol 1992;167:207-211.
14. Gimbrone MA, Cotran RS, Leapman SB, et al.: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974;52:413-427.
15. Blood CH, Zetter BR: Tumour interaction with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.
16. Folkman J: Clinical applications of reaserch on angiogenesis. N Engl J Med 1995a;333:1757-1763.
17. Sypridopoulos I, Sullivan AB, Kearney M, et al.: Estrogen-recptor- mediated inhibition of human endothelial cell apoptosis. Circulation 1997;95:1505-1514.
18. Morales DE, McGowan KA, Grant DS, et al.: Estrogen promotes angiogenic acitivity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995;91:755-763.
19. Gagliardi A, Taylor M, Hennig B, et al.: Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res 1996;1:1101-1106.